BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33731694)

  • 21. USP39 mediates p21-dependent proliferation and neoplasia of colon cancer cells by regulating the p53/p21/CDC2/cyclin B1 axis.
    Yuan J; Li X; Zhang G; Cheng W; Wang W; Lei Y; Ma Q; Song G
    Mol Carcinog; 2021 Apr; 60(4):265-278. PubMed ID: 33634905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. USP39 promotes malignant proliferation and angiogenesis of renal cell carcinoma by inhibiting VEGF-A
    Pan XW; Xu D; Chen WJ; Chen JX; Chen WJ; Ye JQ; Gan SS; Zhou W; Song X; Shi L; Cui XG
    Cancer Cell Int; 2021 Sep; 21(1):486. PubMed ID: 34544400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.
    Kim TH; Song JY; Park H; Jeong JY; Kwon AY; Heo JH; Kang H; Kim G; An HJ
    Cancer Lett; 2015 Jan; 356(2 Pt B):937-45. PubMed ID: 25444913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Splicing factor BUD31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic BCL2L12.
    Wang Z; Wang S; Qin J; Zhang X; Lu G; Liu H; Guo H; Wu L; Shender VO; Shao C; Kong B; Liu Z
    Nat Commun; 2022 Oct; 13(1):6246. PubMed ID: 36271053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. USP39, a direct target of microRNA-133a, promotes progression of pancreatic cancer via the AKT pathway.
    Cai J; Liu T; Huang P; Yan W; Guo C; Xiong L; Liu A
    Biochem Biophys Res Commun; 2017 Apr; 486(1):184-190. PubMed ID: 28286270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Overexpression of high mobility group A2 and its correlation with microRNA let-7 family in serous ovarian cancers].
    Yang J; Zhang Q; Dong JQ; Chang XH; He XJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):749-54. PubMed ID: 23073586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. STC2 overexpression mediated by HMGA2 is a biomarker for aggressiveness of high-grade serous ovarian cancer.
    Wu J; Lai M; Shao C; Wang J; Wei JJ
    Oncol Rep; 2015 Sep; 34(3):1494-502. PubMed ID: 26165228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NFATc1 regulates cell proliferation, migration, and invasion of ovarian cancer SKOV3 cells in vitro and in vivo.
    Li L; Duan Z; Yu J; Dang HX
    Oncol Rep; 2016 Aug; 36(2):918-28. PubMed ID: 27350254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternative splicing of the multidrug resistance protein 1/ATP binding cassette transporter subfamily gene in ovarian cancer creates functional splice variants and is associated with increased expression of the splicing factors PTB and SRp20.
    He X; Ee PL; Coon JS; Beck WT
    Clin Cancer Res; 2004 Jul; 10(14):4652-60. PubMed ID: 15269137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of USP39 predicts poor prognosis and promotes tumorigenesis of prostate cancer via promoting EGFR mRNA maturation and transcription elongation.
    Huang Y; Pan XW; Li L; Chen L; Liu X; Lu JL; Zhu XM; Huang H; Yang QW; Ye JQ; Gan SS; Wang LH; Hong Y; Xu DF; Cui XG
    Oncotarget; 2016 Apr; 7(16):22016-30. PubMed ID: 26959883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NFATC1 promotes cell growth and tumorigenesis in ovarian cancer up-regulating c-Myc through ERK1/2/p38 MAPK signal pathway.
    Xu W; Gu J; Ren Q; Shi Y; Xia Q; Wang J; Wang S; Wang Y; Wang J
    Tumour Biol; 2016 Apr; 37(4):4493-500. PubMed ID: 26501422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockdown of USP39 induces cell cycle arrest and apoptosis in melanoma.
    Zhao Y; Zhang B; Lei Y; Sun J; Zhang Y; Yang S; Zhang X
    Tumour Biol; 2016 Oct; 37(10):13167-13176. PubMed ID: 27456357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long noncoding RNA NEAT1, regulated by LIN28B, promotes cell proliferation and migration through sponging miR-506 in high-grade serous ovarian cancer.
    Yong W; Yu D; Jun Z; Yachen D; Weiwei W; Midie X; Xingzhu J; Xiaohua W
    Cell Death Dis; 2018 Aug; 9(9):861. PubMed ID: 30154460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Construction of let-7d expression vector and its inhibitory effect on HMGA2 and ras expression in human ovarian cancer cells in vitro].
    Ye H; Chen J; Huang X; Guo A; Hao P
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1752-7. PubMed ID: 23268403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The long non-coding RNA LSINCT5 promotes malignancy in non-small cell lung cancer by stabilizing HMGA2.
    Tian Y; Zhang N; Chen S; Ma Y; Liu Y
    Cell Cycle; 2018; 17(10):1188-1198. PubMed ID: 29883241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The lncRNA HULC functions as an oncogene by targeting ATG7 and ITGB1 in epithelial ovarian carcinoma.
    Chen S; Wu DD; Sang XB; Wang LL; Zong ZH; Sun KX; Liu BL; Zhao Y
    Cell Death Dis; 2017 Oct; 8(10):e3118. PubMed ID: 29022892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Splicing Factor PQBP1 Curtails BAX Expression to Promote Ovarian Cancer Progression.
    Liu X; Zhang J; Wang Z; Yan M; Xu M; Li G; Shender V; Wei JJ; Li J; Shao C; Zhang S; Kong B; Song K; Liu Z
    Adv Sci (Weinh); 2024 Apr; 11(15):e2306229. PubMed ID: 38342602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knocking down USP39 Inhibits the Growth and Metastasis of Non-Small-Cell Lung Cancer Cells through Activating the p53 Pathway.
    Yuan J; Zhang G; Li X; Ma Q; Cheng W; Wang W; Zhang B; Hu T; Song G
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The long noncoding RNA HULC promotes liver cancer by increasing the expression of the HMGA2 oncogene via sequestration of the microRNA-186.
    Wang Y; Chen F; Zhao M; Yang Z; Li J; Zhang S; Zhang W; Ye L; Zhang X
    J Biol Chem; 2017 Sep; 292(37):15395-15407. PubMed ID: 28765279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. USP39-mediated deubiquitination of Cyclin B1 promotes tumor cell proliferation and glioma progression.
    Xiao Y; Chen X; Hu W; Ma W; Di Q; Tang H; Zhao X; Huang G; Chen W
    Transl Oncol; 2023 Aug; 34():101713. PubMed ID: 37302347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.